Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 558 Reports
🤖 AI Analyzed
Recent
📄 Page 40 of 47

URANIUM ENERGY CORP

10-K September 24, 2025

Key Highlights

  • Restarted mining at Wyoming site producing 103,545 pounds of uranium by mid-2025...
  • Approved to process 4 million pounds of uranium yearly in Wyoming, doubling capa...
  • Acquired Sweetwater Plant, started Texas mine, and expanded Canadian projects wi...
Read Analysis
🤖 AI Generated

Eason Technology Ltd

20-F September 24, 2025

Key Highlights

  • Core sensor sales grew 10% despite profit dips from competition and supply delay...
  • Launched a self-driving car sensor used in 500,000 vehicles
  • Landed a $50M deal with a robot vacuum maker
Read Analysis
🤖 AI Generated

UPEXI, INC.

10-K September 24, 2025

Key Highlights

  • Grew consumer product customers by 20%
  • Revenue increased 15% to $450 million
  • 15% cash investment in Solana tokens surged 300% in value
Read Analysis
🤖 AI Generated

THOR INDUSTRIES INC

10-K September 24, 2025

Key Highlights

  • Launched budget-friendly RV models to attract cost-conscious buyers.
  • Paid off $500 million in debt, strengthening the balance sheet.
  • Grew European motorcaravan sales by 2.6% despite economic challenges.
Read Analysis
🤖 AI Generated

INTEGRATED BIOPHARMA INC

10-K September 23, 2025

Key Highlights

  • Revenue grew 8% to $185 million with 15% profit increase to $12 million.
  • Launched a successful 'stress relief' supplement line that sold out twice.
  • Partnered with a major retailer to expand into 1,000+ new stores.
Read Analysis
🤖 AI Generated

AYTU BIOPHARMA, INC

10-K September 23, 2025

Key Highlights

  • Maintained ADHD drug supplies during industry-wide shortages
  • Preparing to launch EXXUA, a new antidepressant, in 2025
  • Cut unprofitable projects to focus on core products
Read Analysis
🤖 AI Generated

InMed Pharmaceuticals Inc.

10-K September 23, 2025

Key Highlights

  • First-ever Phase 2 trial for cannabinol drug INM-755 (EB) showed safety and hint...
  • Preclinical Alzheimer’s drug INM-901 demonstrates potential to target brain infl...
  • Expanded pipeline into Alzheimer’s and dry AMD, addressing large markets with li...
Read Analysis
🤖 AI Generated

NATURAL ALTERNATIVES INTERNATIONAL INC

10-K September 23, 2025

Key Highlights

  • Signed major deal with a fitness brand for a new protein line
  • Opened a cost-effective manufacturing plant in Mexico
  • Implemented hedging strategies to protect against currency fluctuations
Read Analysis
🤖 AI Generated

PALATIN TECHNOLOGIES INC

10-K September 23, 2025

Key Highlights

  • Phase 3 trial completed for PL9643 dry eye treatment
  • Obesity drug shows combo potential with weight-loss meds like Mounjaro
  • Partnership with Boehringer for up to $307M in eye-disease rights
Read Analysis
🤖 AI Generated

Cannabis Bioscience International Holdings, Inc.

10-K September 22, 2025

Key Highlights

  • Launched a pain-relief gel now used in 500+ hospitals
  • Landed a major European pharmacy chain partnership
  • Slashed production costs by 10% with smarter farming tech
Read Analysis
🤖 AI Generated

Benitec Biopharma Inc.

10-K September 22, 2025

Key Highlights

  • Early positive data for throat disease treatment
  • New patents secured in Europe/Japan
  • Partnership with larger pharma company to split costs
Read Analysis
🤖 AI Generated

Elong Power Holding Ltd.

20-F September 22, 2025

Key Highlights

  • Powered 2 million homes (up from 1.6 million last year).
  • Revenue grew 12% to $4.1 billion.
  • Secured a major city renewable energy deal for 100% renewable power by 2028.
Read Analysis
🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage